Vitamin D Supplementation and Fractures in Adults: A Systematic Umbrella Review of Meta-Analyses of Controlled Trials.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
17 02 2022
Historique:
received: 04 06 2021
pubmed: 24 10 2021
medline: 3 3 2022
entrez: 23 10 2021
Statut: ppublish

Résumé

The growing number of systematic reviews/meta-analyses (SR/MAs) on vitamin D (± calcium) for fracture prevention has led to contradictory guidelines. This umbrella review aims to assess the quality and explore the reasons for the discrepancy of SR/MAs of trials on vitamin D supplementation for fracture risk reduction in adults. We searched 4 databases (2010-2020), Epistemonikos, and references of included SRs/MAs, and we contacted experts in the field. We used A MeaSurement Tool to Assess systematic Reviews 2 (AMSTAR-2) for quality assessment. We compared results and investigated reasons for discordance using matrices and subgroup analyses (PROSPERO registration: CRD42019129540). We included 13 SR/MAs on vitamin D and calcium (Ca/D) and 19 SR/MAs on vitamin D alone, compared to placebo/control. Only 2 from 10 SRs/MAs on Ca/D were of moderate quality. Ca/D reduced the risk of hip fractures in 8 of 12 SRs/MAs (relative risk [RR] 0.61-0.84), and any fractures in 7 of 11 SR/MAs (RR 0.74-0.95). No fracture risk reduction was noted in SRs/MAs exclusively evaluating community-dwelling individuals or in those on vitamin D alone compared to placebo/control. Discordance in results between SRs/MAs stems from inclusion of different trials, related to search periods and eligibility criteria, and varying methodology (using intention to treat, per-protocol, or complete case analysis from individual trials). Ca/D reduces the risk of hip and any fractures, possibly driven by findings from institutionalized individuals. Individual participant data meta-analyses of patients on Ca/D with sufficient follow-up periods, and subgroup analyses, would unravel determinants for a beneficial response to supplementation.

Identifiants

pubmed: 34687206
pii: 6409080
doi: 10.1210/clinem/dgab742
pmc: PMC8852203
doi:

Substances chimiques

Bone Density Conservation Agents 0
Vitamin D 1406-16-2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

882-898

Subventions

Organisme : FIC NIH HHS
ID : D43 TW009118
Pays : United States
Organisme : NIH HHS
ID : D43 TW009118
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society.

Références

Int J Food Sci Nutr. 2021 Jun;72(4):518-528
pubmed: 33043722
JAMA Netw Open. 2019 Dec 2;2(12):e1917789
pubmed: 31860103
Arch Intern Med. 2006 Feb 27;166(4):424-30
pubmed: 16505262
JAMA. 2018 Apr 17;319(15):1600-1612
pubmed: 29677308
Clin Rheumatol. 2020 Dec;39(12):3571-3579
pubmed: 32447604
BMJ. 2014 Apr 01;348:g2035
pubmed: 24690624
Lancet. 2005 May 7-13;365(9471):1621-8
pubmed: 15885294
N Engl J Med. 1997 Sep 4;337(10):670-6
pubmed: 9278463
J Bone Miner Res. 2010 Jul;25(7):1487-95
pubmed: 20200964
Phys Ther. 2015 Aug;95(8):1095-110
pubmed: 25655877
PLoS One. 2014 Dec 31;9(12):e115934
pubmed: 25551377
Am J Clin Nutr. 2008 Aug;88(2):541S-544S
pubmed: 18689398
J Clin Endocrinol Metab. 2022 Feb 17;107(3):882-898
pubmed: 34687206
Cochrane Database Syst Rev. 2018 Sep 07;9:CD005465
pubmed: 30191554
Am J Med. 2007 May;120(5):381-7
pubmed: 17466644
PLoS One. 2014 Jun 13;9(6):e99308
pubmed: 24926876
J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30
pubmed: 21646368
Medicine (Baltimore). 2020 Aug 21;99(34):e21506
pubmed: 32846760
Osteoporos Int. 2002 Mar;13(3):257-64
pubmed: 11991447
J Clin Endocrinol Metab. 2012 Jun;97(6):1871-80
pubmed: 22466336
Age Ageing. 2004 Jan;33(1):45-51
pubmed: 14695863
Metabolism. 2019 Sep;98:112-120
pubmed: 31226354
Nat Rev Endocrinol. 2017 Aug;13(8):466-479
pubmed: 28387318
Ann Intern Med. 2011 Dec 20;155(12):827-38
pubmed: 22184690
PLoS One. 2015 Jan 20;10(1):e0115850
pubmed: 25602255
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2017 Jun 20;39(3):345-351
pubmed: 28695804
CMAJ. 1997 May 15;156(10):1411-6
pubmed: 9164400
BMC Public Health. 2010 Jun 11;10:331
pubmed: 20540727
Cochrane Database Syst Rev. 2014 Apr 14;(4):CD000227
pubmed: 24729336
Syst Rev. 2015 Jul 23;4:98
pubmed: 26202162
Lancet Diabetes Endocrinol. 2018 Nov;6(11):847-858
pubmed: 30293909
JAMA. 2017 Dec 26;318(24):2466-2482
pubmed: 29279934
Cochrane Database Syst Rev. 2012 Sep 12;(9):CD007146
pubmed: 22972103
J Bone Miner Res. 2012 Sep;27(9):1907-15
pubmed: 22550021
Medicine (Baltimore). 2015 Jun;94(25):e991
pubmed: 26107684
BMJ. 2017 Sep 21;358:j4008
pubmed: 28935701
JAMA. 2017 Nov 7;318(17):1687-1699
pubmed: 29114830
Osteoporos Int. 2016 Jan;27(1):367-76
pubmed: 26510847
Osteoporos Int. 2010 Jul;21(7):1151-4
pubmed: 20422154
J Bone Miner Res. 2007 Apr;22(4):509-19
pubmed: 17243866
N Engl J Med. 2006 Feb 16;354(7):669-83
pubmed: 16481635
N Engl J Med. 2012 Jul 5;367(1):40-9
pubmed: 22762317
BMJ. 2015 Sep 29;351:h4580
pubmed: 26420387
Endocr Rev. 2008 Oct;29(6):726-76
pubmed: 18694980
BMJ Open. 2019 Oct 16;9(10):e024595
pubmed: 31619412
J Bone Miner Res. 2000 Jun;15(6):1113-8
pubmed: 10841179
J Bone Miner Res. 2014 Jul;29(7):1675-80
pubmed: 24535832
Syst Rev. 2018 Oct 12;7(1):159
pubmed: 30314530
Lancet Diabetes Endocrinol. 2014 Jul;2(7):573-80
pubmed: 24768505
BMJ. 2005 Apr 30;330(7498):1003
pubmed: 15860827
Osteoporos Int. 2012 Sep;23(9):2239-56
pubmed: 22419370
Geriatr Gerontol Int. 2011 Apr;11(2):133-42
pubmed: 21134097
Ann Intern Med. 2015 Jan 20;162(2):109-22
pubmed: 25419719
Ann Intern Med. 2010 Dec 21;153(12):815-25
pubmed: 21173416
N Engl J Med. 1992 Dec 3;327(23):1637-42
pubmed: 1331788
J Am Geriatr Soc. 2014 Jan;62(1):147-52
pubmed: 24350602
Eur J Clin Nutr. 2013 Jun;67(6):685
pubmed: 23462947
J Bone Miner Res. 2004 Mar;19(3):370-8
pubmed: 15040824
Curr Med Res Opin. 2010 May;26(5):1193-201
pubmed: 20302551
Syst Rev. 2017 Jul 18;6(1):145
pubmed: 28720141
J Clin Endocrinol Metab. 2007 Apr;92(4):1415-23
pubmed: 17264183
CMAJ. 2010 Sep 7;182(12):E610-8
pubmed: 20624868
Scand J Clin Lab Invest Suppl. 2012;243:60-4
pubmed: 22536764
Eur J Endocrinol. 2019 Apr;180(4):P23-P54
pubmed: 30721133
J Clin Epidemiol. 2014 Apr;67(4):368-75
pubmed: 24581293
Clin Trials. 2004;1(6):490-8
pubmed: 16279289
Endokrynol Pol. 2013;64(4):319-27
pubmed: 24002961
Age Ageing. 1983 May;12(2):124-30
pubmed: 6346829
BMJ. 2010 Jan 12;340:b5463
pubmed: 20068257
Nutrients. 2021 Jul 15;13(7):
pubmed: 34371932
CMAJ. 2012 May 15;184(8):895-9
pubmed: 22158397
J Clin Endocrinol Metab. 2019 May 1;104(5):1623-1630
pubmed: 30907957
J Steroid Biochem Mol Biol. 2018 Jan;175:4-11
pubmed: 27693095
CMAJ. 2020 Aug 10;192(32):E901-E906
pubmed: 32778601
Osteoporos Int. 2013 Feb;24(2):567-80
pubmed: 23208074
Syst Rev. 2016 Nov 14;5(1):190
pubmed: 27842604
Maturitas. 2010 Apr;65(4):359-65
pubmed: 20060665
Ann Nutr Metab. 2012;60(4):241-6
pubmed: 22677925

Auteurs

Marlene Chakhtoura (M)

Calcium Metabolism and Osteoporosis Program, World Health Organization Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Beirut 1107-2020, Lebanon.

Dania S Bacha (DS)

Calcium Metabolism and Osteoporosis Program, World Health Organization Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Beirut 1107-2020, Lebanon.

Charbel Gharios (C)

Calcium Metabolism and Osteoporosis Program, World Health Organization Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Beirut 1107-2020, Lebanon.

Sara Ajjour (S)

Calcium Metabolism and Osteoporosis Program, World Health Organization Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Beirut 1107-2020, Lebanon.

Mariam Assaad (M)

Calcium Metabolism and Osteoporosis Program, World Health Organization Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Beirut 1107-2020, Lebanon.

Yara Jabbour (Y)

Calcium Metabolism and Osteoporosis Program, World Health Organization Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Beirut 1107-2020, Lebanon.

Francesca Kahale (F)

Calcium Metabolism and Osteoporosis Program, World Health Organization Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Beirut 1107-2020, Lebanon.

Aya Bassatne (A)

Calcium Metabolism and Osteoporosis Program, World Health Organization Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Beirut 1107-2020, Lebanon.

Stephanie Antoun (S)

Calcium Metabolism and Osteoporosis Program, World Health Organization Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Beirut 1107-2020, Lebanon.

Elie A Akl (EA)

Department of Internal Medicine, American University of Beirut Medical Center, Beirut 1107-2020, Lebanon.
Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario L8S 4L8, Canada.

Roger Bouillon (R)

Department of Chronic Diseases, Metabolism and Ageing, Katholieke Universiteit Leuven, Leuven 3000, Belgium.

Paul Lips (P)

Department of Internal Medicine, Endocrine Section, Amsterdam University Medical Center, VU University Medical Center, 1007 MB Amsterdam, the Netherlands.

Peter R Ebeling (PR)

Department of Medicine, School of Clinical Sciences, Monash University, Clayton, Victoria 3168, Australia.

Ghada El-Hajj Fuleihan (G)

Calcium Metabolism and Osteoporosis Program, World Health Organization Collaborating Center for Metabolic Bone Disorders, American University of Beirut Medical Center, Beirut 1107-2020, Lebanon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH